Suppr超能文献

抗血小板治疗是否会影响接受腹部腹腔镜手术患者的结局?来自一家三级转诊医院的 1000 多例腹腔镜手术的经验教训。

Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital.

机构信息

Department of Surgery, Kokura Memorial Hospital, Fukuoka, Japan.

出版信息

J Am Coll Surg. 2013 Dec;217(6):1044-53. doi: 10.1016/j.jamcollsurg.2013.08.005. Epub 2013 Sep 17.

Abstract

BACKGROUND

The effect of antiplatelet therapy (APT) on surgical blood loss and perioperative complications in patients receiving abdominal laparoscopic surgery still remains unclear.

STUDY DESIGN

A total of 1,075 consecutive patients undergoing abdominal laparoscopic surgery between 2005 and 2011 were reviewed. Our perioperative management protocol consisted of interruption of APT 1 week before surgery and early postoperative reinstitution in low thromboembolic risk patients (n = 160, iAPT group). Preoperative APT was maintained in patients with high thromboembolic risk or emergent situation (n = 52, cAPT group). Perioperative and outcomes variables of cAPT and iAPT groups, including bleeding and thromboembolic complications, were compared with those of patients without APT (non-APT group, n = 863).

RESULTS

In this cohort, 715 basic and 360 advanced laparoscopic operations were included. No patient suffering excessive intraoperative bleeding due to continuation of APT was observed. There were 10 postoperative bleeding complications (0.9%) and 3 thromboembolic events (0.3%), but the surgery was free of both complications in the cAPT group. No significant differences were found between the groups in operative blood loss, blood transfusion rate, and the occurrence of bleeding and thromboembolic complications. Multivariable analyses showed that multiple antiplatelet agents (p = 0.015) and intraoperative blood transfusion (p = 0.046) were significant prognostic factors for postoperative bleeding complications. Increased thromboembolic complications were independently associated with high New York Heart Association class (p = 0.019) and history of cerebral infarction (p = 0.048), but not associated with APT use.

CONCLUSIONS

Abdominal laparoscopic operations were successfully performed without any increase in severe complications in patients with APT compared with the non-APT group under our rigorous perioperative assessment and management. Maintenance of single APT should be considered in patients with high thromboembolic risk, even when an abdominal laparoscopic approach is considered.

摘要

背景

抗血小板治疗(APT)对接受腹部腹腔镜手术的患者的手术失血和围手术期并发症的影响仍不清楚。

研究设计

回顾了 2005 年至 2011 年间接受腹部腹腔镜手术的 1075 例连续患者。我们的围手术期管理方案包括在手术前 1 周中断 APT,并且在低血栓栓塞风险患者中早期术后重新开始(n = 160,iAPT 组)。在高血栓栓塞风险或紧急情况下的患者中维持术前 APT(n = 52,cAPT 组)。比较 cAPT 和 iAPT 组与无 APT 组(非 APT 组,n = 863)的围手术期和结局变量,包括出血和血栓栓塞并发症。

结果

在该队列中,包括 715 例基础腹腔镜手术和 360 例高级腹腔镜手术。没有观察到由于继续使用 APT 而导致术中出血过多的患者。术后有 10 例出血并发症(0.9%)和 3 例血栓栓塞事件(0.3%),但 cAPT 组手术无并发症。各组之间的手术失血量、输血率以及出血和血栓栓塞并发症的发生率无显著差异。多变量分析显示,多种抗血小板药物(p = 0.015)和术中输血(p = 0.046)是术后出血并发症的显著预后因素。增加的血栓栓塞并发症与高纽约心脏协会分级(p = 0.019)和脑梗死史(p = 0.048)独立相关,而与 APT 使用无关。

结论

与非 APT 组相比,在我们严格的围手术期评估和管理下,接受 APT 的患者进行腹部腹腔镜手术并未增加严重并发症的风险。即使考虑采用腹部腹腔镜方法,也应考虑在高血栓栓塞风险患者中维持单一 APT。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验